is zepbound a glp-1 agonist New studies suggest drugs may have cancer-preventive effects Weight Loss: Is Zepbound or

The role of glucose in cognition, risk of dementia, and related biomarkers in individuals without type 2 diabetes mellitus or the metabolic syndrome: A systematic review of observational studies

The distinction is between the weight loss branded versions (Wegovy, Zepbound, Saxenda) and the diabetes-indicated versions of the same active ingredients

The ATTAIN-1 Phase 3 trial provides the first large-scale GI data for an oral small-molecule GLP-1 drug

To support drug discovery in this field, Axxam has developed a comprehensive metabolic assay platform

Ozempic contains the active ingredient semaglutide

A drug may improve metabolic risk